MONDAY, June 6, 2022 (HealthDay News) — A small study delivers startling results on the power of a new immunotherapy treatment against rectal cancer: The drug triggered remission in all the patients who got it. All of them had mismatch repair-deficient (MMRd) locally advanced rectal cancer and were given dostarlimabContinue Reading

MONDAY, June 6, 2022 (HealthDay News) — New research points to a compelling interplay between inflammatory bowel disease (IBD) and depression. IBD includes Crohn’s disease and ulcerative colitis. In addition to the physical pain that these illnesses can inflict upon sufferers, the new study showed that patients face a significantlyContinue Reading